Physician profile
Yanfeng Chen
NPI 1740280171
$58,590.77
in general payments reported to CMS, 2019-2025
44 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $2,781 · 2021: $7,099 · 2022: $5,972 · 2023: $6,482 · 2024: $13K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,776.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,440.00 |
| Education | $119.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $36,169.00 | 2019-2025 | Vemlidy, Livdelzi |
| Astrazeneca Pharmaceuticals Lp | $4,691.32 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $3,497.77 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,188.90 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Amgen INC. | $1,929.95 | 2019-2025 | Repatha, Evenity, Otezla |
| Novo Nordisk INC | $1,585.55 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,234.10 | 2019-2025 | Ubrelvy, Qulipta |
| Amarin Pharma, INC. | $737.35 | 2019-2023 | |
| Lilly USA, LLC | $710.33 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $486.33 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $485.35 | 2019-2021 | |
| Exact Sciences Corporation | $455.87 | 2023-2025 | Cologuard Collection Kit |
| Philips North America LLC | $397.30 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Madrigal Pharmaceuticals | $381.64 | 2025 | Rezdiffra |
| Pfizer INC. | $336.86 | 2019-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $299.71 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.61 | 2019-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $249.55 | 2019-2024 | Veozah, Myrbetriq |
| Esperion Therapeutics, INC. | $229.05 | 2020-2024 | Nexletol |
| Ibsa Pharma INC. | $226.43 | 2021-2022 | |
| Insmed, INC. | $179.47 | 2019-2025 | Brinsupri, Arikayce |
| Stryker Corporation | $166.67 | 2023 | Mako |
| Kowa Pharmaceuticals America, INC. | $154.45 | 2019-2025 | Zoryve |
| Ardelyx, INC. | $147.73 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $147.22 | 2023-2025 | |
| Angiodynamics, INC. | $125.00 | 2024 | Nanoknife |
| Beone Medicines USA, INC. | $125.00 | 2025 | Brukinsa |
| E.R. Squibb & Sons, L.L.C. | $124.76 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $123.09 | 2019 | |
| Hikma Pharmaceuticals USA | $116.34 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $78.84 | 2024 | Nuzyra |
| Sanofi Pasteur INC. | $77.22 | 2019-2025 | |
| Radius Health, INC. | $71.12 | 2020-2021 | |
| Abbott Laboratories | $70.06 | 2021 | |
| Advanced Respiratory, INC | $58.64 | 2020 | |
| Aimmune Therapeutics, INC. | $55.53 | 2025 | Vowst, Zenpep |
| Sanofi-Aventis U.S. LLC | $45.14 | 2019 | |
| Phadia US INC. | $43.27 | 2024-2025 | Immunocap |
| Seqirus USA INC | $30.00 | 2025 | Fluad, Flucelvax |
| Smith+Nephew, INC. | $26.67 | 2025 | Collagenase Santyl |
| Horizon Therapeutics Plc | $20.00 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.00 | 2020 | |
| Baxter Healthcare | $18.83 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Krystal Biotech INC | $18.75 | 2024 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanfeng Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.